706793-18-2 Usage
Derivative of benzotriazole
Benzotriazole is the parent compound This compound is derived from benzotriazole, which is a well-known chemical structure commonly used in various applications.
Corrosion inhibitor
It can be used to prevent or slow down the corrosion of metals One of the primary uses of this compound is as a corrosion inhibitor, helping to protect metal surfaces from degradation.
Production of UV stabilizers
It is used in the synthesis of materials that protect against harmful ultraviolet (UV) radiation This compound may be used in the production of UV stabilizers, which are additives that help prevent the degradation of materials when exposed to UV radiation.
Photographic chemicals
It has applications in the production and processing of photographic materials This compound may be used in the development, processing, or preservation of photographic materials.
Methyl ester
The compound is a methyl ester of 7-amino-1H-benzotriazole-5-carboxylic acid The ester functional group is formed by the reaction of an acid with an alcohol, in this case, attaching a methyl group to the 7-amino-1H-benzotriazole-5-carboxylic acid.
Applications in organic synthesis
It may be used as a building block or reagent in the synthesis of other organic compounds This compound could be useful in the creation of other chemical structures through organic synthesis.
Pharmaceuticals
It may have potential applications in the development of pharmaceutical drugs The compound could be used as an active ingredient or as a precursor in the synthesis of pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 706793-18-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,6,7,9 and 3 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 706793-18:
(8*7)+(7*0)+(6*6)+(5*7)+(4*9)+(3*3)+(2*1)+(1*8)=182
182 % 10 = 2
So 706793-18-2 is a valid CAS Registry Number.
706793-18-2Relevant articles and documents
Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics
Charrier, Nicolas,Clarke, Brian,Cutler, Leanne,Demont, Emmanuel,Dingwall, Colin,Dunsdon, Rachel,Hawkins, Julie,Howes, Colin,Hubbard, Julia,Hussain, Ishrut,Maile, Graham,Matico, Rosalie,Mosley, Julie,Naylor, Alan,O'Brien, Alistair,Redshaw, Sally,Rowland, Paul,Soleil, Virginie,Smith, Kathrine J.,Sweitzer, Sharon,Theobald, Pam,Vesey, David,Walter, Daryl S.,Wayne, Gareth
scheme or table, p. 3664 - 3668 (2010/03/24)
Inhibition of the aspartyl protease BACE-1 has the potential to deliver a disease-modifying therapy for Alzheimer's disease. We have recently disclosed a series of transition-state mimetic BACE-1 inhibitors showing nanomolar potency in cell-based assays.
